Evidence map›Paper›PMID 34725422›Full record

ArticleScientific reports2021

Within patient genetic diversity of bla

Deisy Abril, Erika Vergara, Diana Palacios, Aura Lucía Leal, Ricaurte Alejandro Marquez-Ortiz, Johana Madroñero, Zayda Lorena Corredor Rozo, Zandra De La Rosa, Carlos A Nieto, Natasha Vanegas and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Emergence ofAntibiotics (Basel, Switzerland) · 2025
    Article
  5. New Insights inAntibiotics (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Plant-Origin Components: New Players to Combat Antibiotic Resistance inInternational journal of molecular sciences · 2024
    Review
  11. Article
  12. Article
  13. Co-Harboring of Beta-Lactamases andAntibiotics (Basel, Switzerland) · 2023
    Article
  14. Worldwide Dissemination ofAntibiotics (Basel, Switzerland) · 2023
    Review
  15. Genomic characterization of two carbapenem-resistantFrontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Deisy AbrilBacterial Molecular Genetics Laboratory, Universidad El Bosque, Carrera 9 #131A-02, Bogota, Colombia.
Erika VergaraFacultad de Medicina y Grupo de Investigación en Enfermedades Infecciosas, Universidad Nacional de Colombia, Bogotá, Colombia.
Diana PalaciosDepartamento de Patología y Laboratorios, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Aura Lucía LealFacultad de Medicina y Grupo de Investigación en Enfermedades Infecciosas, Universidad Nacional de Colombia, Bogotá, Colombia.
Ricaurte Alejandro Marquez-OrtizBacterial Molecular Genetics Laboratory, Universidad El Bosque, Carrera 9 #131A-02, Bogota, Colombia.
Johana MadroñeroBacterial Molecular Genetics Laboratory, Universidad El Bosque, Carrera 9 #131A-02, Bogota, Colombia.
Zayda Lorena Corredor RozoBacterial Molecular Genetics Laboratory, Universidad El Bosque, Carrera 9 #131A-02, Bogota, Colombia.
Zandra De La RosaDepartamento de Patología y Laboratorios, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Carlos A NietoBacterial Molecular Genetics Laboratory, Universidad El Bosque, Carrera 9 #131A-02, Bogota, Colombia.
Natasha VanegasBacterial Molecular Genetics Laboratory, Universidad El Bosque, Carrera 9 #131A-02, Bogota, Colombia.
Jorge A CortésFacultad de Medicina y Grupo de Investigación en Enfermedades Infecciosas, Universidad Nacional de Colombia, Bogotá, Colombia.
Javier Escobar-PerezBacterial Molecular Genetics Laboratory, Universidad El Bosque, Carrera 9 #131A-02, Bogota, Colombia. escobarjavier@unbosque.edu.co.ORCID 0000-0002-0432-6978
Universidad El Bosque · COUniversidad Nacional de Colombia · COFundación Santa Fe de Bogotá · COUniversity of Technology Sydney · AU

Funding

Ministerio de Ciencia, Tecnología e Innovación of Colombia-MinCiencias 1308-77758007
6 · The paper itself

Abstract

Resistance to carbapenems in Klebsiella pneumoniae has been mostly related with the worldwide dissemination of KPC, largely due to the pandemic clones belonging to the complex clonal (CC) 258. To unravel bla

Indexed as

Drug Resistance, BacterialAdolescentAdultAgedAged, 80 and overBacterial Proteinsbeta-LactamasesCarbapenemsColombiaFemaleGenetic VariationGenome, BacterialGenomicsHospitalizationHospitalsHumansBacterial Proteinsbeta-lactamase KPC-2, Klebsiella pneumoniaebeta-lactamase KPC-3, Klebsiella pneumoniaebeta-LactamasesCarbapenems

Identifiers

PMID34725422
PMCPMC8560879
OpenAlexW3210522317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.